Putative mechanism of CRP’s relationship to polyneuritis equi assay results
I spoke with Dr. Stefan Rose John, Institute of Biochemistry in Kiel Germany, a few years ago. Work he published in 2012 explains the...
Pathogenes mission is to develop patent protected technologies for the diagnosis and treatment of parasitic diseases.
Putative mechanism of CRP’s relationship to polyneuritis equi assay results
Endpoints in clinical trials have to be relevant
Field Effectiveness Study for PNE
Innate immune responses to S. neurona
S. neurona SAG 6 gets attention
Cell danger response: EPM or PNE?
Identification of biomarkers to slow neurodegenerative diseases
What does it take to bring drug to market? Can I give it away to patients?
Pathogenes Newsletter January 2023
The difference between “EPM” testing formats
Predicting the severity of EPM is possible
What is the difference between EPM, EMS, and PNE (polyneuritis)
Gathering Data on EPM and PNE (polyneuritis equi)
The MP2/MPP ELISA in the differential diagnosis of polyneuritis (PNE)
Interpreting S. neurona antibody tests
Can PNE (polyneuritis) be diagnosed with NfL found in serum, plasma, or exosomes?
Test twice, treat once The PNE (polyneuritis) plan
Innate Biomarkers for EPM and PNE (polyneuritis)